These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1871432)

  • 1. Studies on the role of the mycobacterial cell envelope in the multiple drug resistance of atypical mycobacteria.
    Hoffner SE; Svenson SB
    Res Microbiol; 1991 May; 142(4):448-51. PubMed ID: 1871432
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.
    Tsang AY; Bentz RR; Schork MA; Sodeman TM
    Am J Clin Pathol; 1978 Nov; 70(5):816-20. PubMed ID: 717288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].
    Golychevskaja VI
    G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare.
    Heifets LB
    Am Rev Respir Dis; 1982 Jan; 125(1):43-8. PubMed ID: 7065508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
    Banks J; Jenkins PA
    Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid.
    Hjelm U; Kaustová J; Kubín M; Hoffner SE
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):51-4. PubMed ID: 1563386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.
    Yates MD; Collins CH
    Tubercle; 1981 Jun; 62(2):117-21. PubMed ID: 7303160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on the action of rifampin and ethambutol alone and in combination with other antituberculous drugs.
    Hobby GL; Lenert TF
    Am Rev Respir Dis; 1972 Feb; 105(2):292-5. PubMed ID: 4621612
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 11. [Distribution and drug resistance of nontuberculous
    Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiometric susceptibility testing of Mycobacterium xenopi.
    Tortoli E; Simonetti MT
    J Chemother; 1995 Apr; 7(2):114-7. PubMed ID: 7666116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL; Johnson PM; Boytar-Papirnyik V; Wilber J
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between lipid composition and antibiotic-resistance to isoniazid, streptomycin, p-aminosalicylic acid, ethambutol, rifampicin in mycobacteria.
    Alberghina M
    Ital J Biochem; 1976; 25(2):127-51. PubMed ID: 962981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. II. The role of rifampicin and other drugs in the dependent or independent action of drug associations in vitro.
    Trnka L; Mison P; Staflova S
    Chemotherapy; 1974; 20(2):82-91. PubMed ID: 4210894
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare.
    Franzblau SG; Takeda T; Nakamura M
    Microbiol Immunol; 1986; 30(9):903-7. PubMed ID: 3540539
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.